VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_13-vv-00252
Package ID: USCOURTS-cofc-1_13-vv-00252
Petitioner: EDWINA BRADSHAW
Filed: 2014-02-03
Decided: 2014-02-06
Vaccine: influenza
Vaccination date: 2010-10-06
Condition: Guillain-Barré syndrome (“GBS”)
Outcome: compensated
Award amount USD: 100000

AI-assisted case summary:
Edwina Bradshaw received an influenza vaccine on October 6, 2010. She alleged that this vaccine caused her to develop Guillain-Barré syndrome (GBS) and that she experienced residual effects for more than six months. Respondent denied that the flu vaccine caused her GBS or any other condition. The parties reached a stipulation to resolve the case. The court awarded Edwina Bradshaw $100,000.00 for all damages. Separately, the parties stipulated to attorneys' fees and costs, and the court awarded $14,322.11.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_13-vv-00252-0
Date issued/filed: 2014-02-25
Pages: 7
Docket text: PUBLIC DECISION Signed by Special Master Laura D Millman. (tlj) Copy to parties.
--------------------------------------------------------------------------------
Case 1:13-vv-00252-UNJ Document 25 Filed 02/25/14 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 13-252V
Filed: February 3, 2014
Not for Publication
*************************************
EDWINA BRADSHAW, *
*
Petitioner, *
* Damages decision based on stipulation;
v. * flu vaccine; Guillain-Barré syndrome
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
*
*************************************
Peter J. Sarda, Raleigh, NC, for petitioner.
Jennifer L. Reynaud, Washington, DC, for respondent.
MILLMAN, Special Master
DECISION AWARDING DAMAGES1
On February 3, 2014, the parties filed the attached stipulation in which they agreed to settle
this case and described the settlement terms. Petitioner alleges that she suffered Guillain-Barré
syndrome (“GBS”) that was caused by her October 6, 2010, receipt of influenza (“flu”) vaccine.
She further alleges that she experienced the residual effects of this injury for more than six months.
Respondent denies that flu vaccine caused petitioner’s GBS and residual effects, any other injury,
or her current condition. Nonetheless, the parties agreed to resolve this matter informally.
1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this
case, the special master intends to post this unpublished decision on the United States Court of Federal
Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899,
2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made
available to the public unless they contain trade secrets or commercial or financial information that is
privileged and confidential, or medical or similar information whose disclosure would constitute a clearly
unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and
move to delete such information prior to the document’s disclosure. If the special master, upon review,
agrees that the identified material fits within the banned categories listed above, the special master shall
delete such material from public access.

Case 1:13-vv-00252-UNJ Document 25 Filed 02/25/14 Page 2 of 7
The undersigned finds the terms of the stipulation to be reasonable. The court hereby
adopts the parties’ said stipulation, attached hereto, and awards compensation in the amount and
on the terms set forth therein. Pursuant to the stipulation, the court awards a lump sum of
$100,000.00, representing compensation for all damages that would be available under 42 U.S.C.
§ 300aa-15(a) (2012). The award shall be in the form of a check for $100,000.00 made payable to
petitioner.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the
court is directed to enter judgment herewith.2
IT IS SO ORDERED.
Dated: February 3, 2014 s/ Laura D. Millman
Laura D. Millman
Special Master
2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or
jointly, filing a notice renouncing the right to seek review.
2

Case 1:13-vv-00252-UNJ Document 25 Filed 02/25/14 Page 3 of 7

Case 1:13-vv-00252-UNJ Document 25 Filed 02/25/14 Page 4 of 7

Case 1:13-vv-00252-UNJ Document 25 Filed 02/25/14 Page 5 of 7

Case 1:13-vv-00252-UNJ Document 25 Filed 02/25/14 Page 6 of 7

Case 1:13-vv-00252-UNJ Document 25 Filed 02/25/14 Page 7 of 7
February 3, 2014

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_13-vv-00252-1
Date issued/filed: 2014-02-25
Pages: 2
Docket text: PUBLIC DECISION Signed by Special Master Laura D Millman. (tlj) Copy to parties.
--------------------------------------------------------------------------------
Case 1:13-vv-00252-UNJ Document 26 Filed 02/25/14 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 13-252V
Filed: February 6, 2014
Not for Publication
*************************************
EDWINA BRADSHAW, *
*
Petitioner, * Attorneys’ fees and costs decision based on
* stipulation of fact
v. *
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
*
*************************************
Peter J. Sarda, Raleigh, NC, for petitioner.
Jennifer L. Reynaud, Washington, DC, for respondent.
MILLMAN, Special Master
DECISION AWARDING ATTORNEYS’ FEES AND COSTS1
On February 6, 2014, the parties filed a stipulation of fact in which they agreed on an
appropriate amount for attorneys’ fees and costs in this case.
In accordance with the General Order #9 requirement, petitioner asserts that she did not
incur any out-of-pocket expenses in pursuit of her petition. Petitioner submitted her request for
attorneys’ fees and costs to respondent. During informal discussions, respondent raised
objections to certain items in petitioner’s application. Based on these objections, petitioner
1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this
case, the special master intends to post this unpublished decision on the United States Court of Federal
Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899,
2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made
available to the public unless they contain trade secrets or commercial or financial information that is
privileged and confidential, or medical or similar information whose disclosure would constitute a clearly
unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and
move to redact such information prior to the document=s disclosure. If the special master, upon review,
agrees that the identified material fits within the banned categories listed above, the special master shall
redact such material from public access.

Case 1:13-vv-00252-UNJ Document 26 Filed 02/25/14 Page 2 of 2
amends her request for reimbursement for attorneys’ fees and costs to $14,322.11. Respondent
does not object to this amount. The undersigned finds this amount to be reasonable.
Accordingly, the court awards $14,322.11, representing reimbursement for attorneys’ fees and
costs. The award shall be in the form of a check made payable jointly to petitioner and Creech
Law Firm, P.A. in the amount of $14,322.11.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the
court is directed to enter judgment herewith.2
IT IS SO ORDERED.
Dated: February 6, 2014 s/ Laura D. Millman
Laura D. Millman
Special Master
2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or
jointly, filing a notice renouncing the right to seek review.
2